Volume 23, Issue 3 pp. 199-202

Determination of dosage requirements of warfarin in Iranian patients using HPLC technique

P. Andalibi

P. Andalibi

Department of Biochemistry, Faculty of Medicine, Kordestan University of Medical Sciences, Sannandaj, Kordestan, Iran

Search for more papers by this author
H. Farsam

H. Farsam

Department of Medicinal Chemistry, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran

Search for more papers by this author
M. Amanlou

M. Amanlou

Department of Medicinal Chemistry, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran

Search for more papers by this author
M. Gharouni

M. Gharouni

Department of Cardiology, Amir-A’lam hospital, Faculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran

Search for more papers by this author
First published: 09 October 2008
Citations: 6
HassanFarsam Department of Medicinal Chemistry, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran

Abstract

In this study the warfarin level in the plasma of 60 patients receiving different dosage regimens of warfarin were determined by HPLC. The corresponding prothrombin times (PT) were also measured. The steady state plasma level of warfarin in 10 healthy volunteers was 900·7±158·21 ng/ml. A mean dose of 3·79±1·02 mg of warfarin corresponded to a therapeutic level of 1193·81±300·35 ng/ml with a mean PT of 20·13±0·69 s. The results of this study suggest that Iranian subjects are more sensitive to warfarin than North American and European subjects, but have responses very similar to those of Asians. Dietary, ethnic and geographical factors as well as differences in drug dispensition may be the cause of the observed dosage variability of warfarin.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.